跳至主要内容
临床试验/CTRI/2019/07/020335
CTRI/2019/07/020335已完成不适用

To evaluate in-vivo safety and efficacy of the skin care formulation in terms of non-comedogenic effect on healthy human subjects.

Em Em Personal Care Pvt Ltd1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2019年7月29日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
36
试验地点
1
主要终点
Safety & Efficacy assessment of products

研究概览

简要总结

The in-vivo safety and efficacy of the skincare formulation in terms of non-comedogenic effect on healthy human subjects.

研究设计

研究类型
Interventional
分配方式
Other

入排标准

年龄范围
18.00 Year(s) 至 30.00 Year(s)(—)
性别
Female

入选标准

  • Having oily or mixed oily skin on the face.

排除标准

  • For female: Do not take part in any family planning activities leading to pregnancy and breastfeeding -Do not take part in another study liable to interfere with this study -Do not take medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol).
  • Do not change her/his cosmetic habits apart from the particular conditions mentioned in the protocol, on the studied anatomic unit.

结局指标

主要结局

Safety & Efficacy assessment of products

时间窗: Screening, T0 days, T14 days, T28 days

次要结局

  • Safety(Screenig,T0, T14 days, T28 days)

研究者

发起方
Em Em Personal Care Pvt Ltd
申办方类型
Other [fmcg]

研究点 (1)

Loading locations...

相似试验